Understanding Racial and Ethnic Identity in Federal Data and Impacts for Health Disparities

How race, ethnicity, and nationality have been defined and measured has important implications for health disparities, affecting who can access health, social, and economic resources. While narrow and inconsistent race and ethnicity categories have obscured inequities and limited the ability to address the diverse needs of different populations, data on race and ethnicity have also…

Read More

FDA Approval Puts New Cytokinetics Heart Drug in Competition With Fast-Growing BMS Med

Cytokinetics drug Myqorzo won FDA approval for treating obstructive hypertrophic cardiomyopathy, or oHCM. Compared to Bristol Myers Squibb’s projected blockbuster drug Camzyos, the Cytokinetics daily pill has less restrictive safety and monitoring requirements, giving it a competitive advantage, according to analysts. The post FDA Approval Puts New Cytokinetics Heart Drug in Competition With Fast-Growing BMS…

Read More

60+ Companies Join CMS’ New Initiative for Data Interoperability & Patient-Facing Apps

CMS launched a new initiative to promote better data interoperability and digital health innovation. As part of the effort, more than 60 organizations pledged to build patient-facing apps and support secure data sharing — including OpenAI, Amazon, Apple, Cleveland Clinic and Providence. The post 60+ Companies Join CMS’ New Initiative for Data Interoperability & Patient-Facing…

Read More